Vijay Pande on Muck Rack

Vijay Pande

  • Member Board of Directors, Function Health
Menlo Park
As seen in: Apple Podcasts, MSN, The New York Times, Forbes, Nature, TIME, Stanford University, TechCrunch, The Wall Street Journal, WIRED (UK) and
Co-Founder at @VZVCfund. Investing in companies solving humanity’s biggest problems, led by founders hell bent on bending the curve.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Vijay

Contact Vijay, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Investing in Slingshot AI

|
By Vijay Pande, Daisy Wolf, Bryan Kim, Zach Cohen
| a16z
Today, we’re proud to announce we’ve led the Series A for Slingshot, the world’s first foundation model for psychology. This brings the total capital raised for the company to $40 million. Mental health has never been worse. While modern life is better than historical times on most dimensions, we’re increasingly lonely, sad, and anxious. Half of the world’s population will develop a mental health disorder in their lifetime.
Open in Who Shared Issue with article?

A father of modern AI wants to reinvent biology

|
By Fred Vogelstein, Vijay Pande
| Crazy Stupid Tech
By Fred Vogelstein When you talk to Jakob Uszkoreit you have to bring your “A“ game. It's not because he's evasive. It's because the stuff he's working on is cutting edge enough that you need every neuron firing to keep up with what he's talking about. Uszkoreit is one of the fathers of modern AI. In 2017 he was one of eight authors of Attention is All You Need, known to many as the Transformer paper.
Open in Who Shared Issue with article?

Announcement: Andreessen Horowitz Partners with Lilly to Launch First-of-Its-Kind Biotech Ecosystem Fund

|
By Julie Yoo, Daisy Wolf, Vijay Pande
| a16z
Andreessen Horowitz (a16z) Bio + Health today announced a newly formed, first-of-its-kind venture capital fund to fuel broader innovation in human health, in partnership with Eli Lilly and Company (“Lilly”). The Biotech Ecosystem Venture Fund (“Fund”) seeks to drive transformative progress in healthcare by investing in therapeutic platforms and cutting-edge technology companies that can bring new medicines and disease treatments to improve patients’ lives.
Open in Who Shared Issue with article?
See all 203 licensed articles (216 Total)
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified